TScan Therapeutics updates corporate presentation with adjusted timelines and pipeline updates

TScan Therapeutics, Inc.

Company furnished updated corporate presentation on September 9, 2025 for investor meetings.
Presentation includes adjusted timelines for solid tumor program and pipeline updates across hematologic malignancies and solid tumors.
Updates on target discovery initiatives in autoimmunity also included; specific numerical details not disclosed in filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.